Skip to content

Consequences of short-term hypo- and hyperthyroidism on brain structure and function in humans

Consequences of short-term hypo- and hyperthyroidism on brain structure and function in humans

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011275
Enrollment
40
Registered
2016-11-16
Start date
2013-03-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of mild hyper- and hypothyroidism

Interventions

Group 1: Induction of mild biochemical hyper- or hypothyroidism by application of thyroxine to healthy volunteers or by reduction of the thyroxine dose in patients depending on a full thyroxine substi

Sponsors

Klinik für NeurologieUKSH Campus Lübeck
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Hyperthyroidism: healthy volunteers Hypothyroidism: patients under thyroxine substitution

Exclusion criteria

Exclusion criteria: any severe general disease, no cardovascular diseases

Design outcomes

Primary

MeasureTime frame
Cognitive functions were assessed by resting state and functional MRI under short-term memory challenge. Arterial spin labelling, voxel based morphometry as well as a battery of neuropsychological tests (visual analogue scale for hyper- or hypothyroidism, battery for attention testing, attention network task, trail making task, auditory verbal learning test both during euthyroidism and following 8 weeks of alteration of thyroid function as tested by thyroid function tests in the 2 groups of test subjects will be used.

Secondary

MeasureTime frame
New biomarkers derived from serum and plasma samples in parallel to the samples obtained for thyroid function tests will be used. During the alteration of thyroid function but also in the recovery period up to 8 weeks after we will use an unsupervised approach by the help of proteomics and metabolomics techniques.

Countries

Germany

Contacts

Public ContactThomas Münte

Klinik für NeurologieUKSH Campus Luebeck

thomas.muente@neuro.uni-luebeck.de045150043400

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 11, 2026